Meet Coco Alinsug, A Friendly Rectal Microbicide Advocate

Check out this interesting mini-bio of  Coco Alinsug, the latest in IRMA's "Meet a Friendly Rectal Microbicide Advocate" series on the IRMA website here.  Coco is one of five new bios posted this week.

  
Coco Alinsung
Boston, Massachusettes, USA

A native of the Philippines and a resident of Lynn, Massachusetts with his partner, Coco Alinsug has made a lifelong commitment to devote his time and energy to social justice, HIV/AIDS prevention, and issues facing LGBT youth.

Coco started his career as an HIV Counselor and Tester at the Gay and Bi Men's Health Program in Beverly, MA and later was appointed as the Executive Director of the North Shore Alliance on GLBT Youth which is funded by the Massachusetts Department of Public Health to provide HIV/STI education to youth 14-24 years old - a position he has held for eight years.

Currently Coco works as the Clinical Trials Field Recruitment Manager at The Fenway Institute where he has been for nearly seven years. It was in this role that Coco first came into contact with rectal microbicide advocacy as he was tasked with recruitment for all clinical trials, including the rectal microbicide study called Project Gel.

In his role at Fenway, Coco oversees outreach and recruitment for research studies looking at everything from possible HIV vaccines to microbicides to the use of pre-exposure prophylaxis (PrEP) to prevent HIV transmission. Coco and his team travel around New England, educating people about HIV and STD transmission and safer sex practices while also recruiting potential study participants.

Coco is also Chair for Community Education and Recruitment group for both HIV Vaccine Trials Network (HVTN) and HIV Prevention Trials Network (HPTN) and sits as a member of the protocol team for two studies, HVTN505 and HPTN069. Coco also is a consultant for various HIV and STD Outreach Programs both in the North Shore and Boston, and sometimes organizes and hosts shows in several clubs.

Coco would also like to encourage IRMA to keep up the good work and always stay fabulous.

Thank you for all your work Coco, and you stay fabulous too!


------------------- *Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at rectalmicro@gmail.com. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.

*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.

*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article's content. -------------------

Oral and Anal Sex Practices Among High Schoolers in Addis Ababa, Ethiopia

via BMC Public Health, by Amsale Cherie and Yemane Berhane

Background

Understanding the full range of sexual behaviors of young people is crucial in developing appropriate interventions to prevent and control sexually transmitted infections including HIV. However, such information is meager in developing countries. The objective of this study was to describe oral and anal sex practices and identify associated factors among high school youth.

Methods

A cross-sectional study was conducted among high school youth in Addis Ababa, Ethiopia. A multi-stage sampling procedure was followed to select a representative sample of school youth. The total sample size for this study was 3840. Data were collected using a self-administered questionnaire. Data analysis was guided by the ecological framework.

Results

The overall proportion of people who reported ever having oral sex was 5.4% (190) and that of anal sex was 4.3% (154). Of these 51.6% (98) had oral sex and 57.1% (87) had anal sex in the past 12 months. Multiple partnerships were reported by 61.2% of the respondents who had oral sex and 51.1% of students practicing anal sex. Consistent condom use was reported by 12.2% of those practicing oral sex and 26.1% of anal sex. Reasons for oral and anal sex included prevention of pregnancy, preserving virginity, and reduction of HIV and STIs transmission. Oral sex practice was strongly and significantly associated with perception of best friends engagement in oral sex (AOR = 5.7; 95% CI 3.6-11.2) and having illiterate mothers (AOR = 11.5; 95%CI 6.4-18.5). Similarly, anal sex practice was strongly and significantly associated with favorable attitude towards anal sex (AOR = 6.2; 95%CI 3.8-12.4), and perceived best friends engagement in anal sex (AOR = 9.7; 95%CI 5.4-17.7).

Conclusion

Considerable proportion of adolescents had engaged in oral and anal sex practices. Multiple sexual partnerships were common while consistent condom use was low. Sexual health education and behavior change communication strategies need to cover a full range of sexual practices.

Read the full study here.


[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

CDC awards $55 million for HIV prevention among gay, bisexual and transgender youth of color

via NCHHSTP Newsroom

The Centers for Disease Control and Prevention today awarded $55 million over five years to 34 community-based organizations (CBOs) to expand HIV prevention services for young gay and bisexual men of color, transgender youth of color, and their partners. The awards expand upon a previous program to reach these populations with an increase of $10 million to fund a larger number of community organizations. The average award for each organization is approximately $300,000 per year.

“On this National Gay Men’s HIV/AIDS Awareness Day, we are reminded of the urgency of the HIV epidemic in the United States and the dramatic impact among gay and bisexual men, who account for more than 60 percent of new infections,” said Dr. Jonathan Mermin, director of CDC’s Division of HIV/AIDS Prevention. “We must also recognize that the epidemic cannot be overcome without effectively addressing the severe and rising toll of HIV infections among gay and bisexual men of color, who continue to be hardest hit by this disease.”

Recent data show that young men who have sex with men (MSM) of color are at particularly high and increasing risk of HIV infection. According to CDC estimates released in August, between 2006 and 2009, the annual number of new HIV infections increased 48 percent among young black MSM. Among Latinos, men who have sex with men are by far the most severely impacted, accounting for nearly two-thirds of all new infections. Nearly half of these infections among Latino MSM occurred in the youngest age group (aged 13-29). Transgender people are also severely affected by HIV. It is estimated that 28 percent of transgender people are HIV-infected.

The new CDC awards are designed to enable CBOs with strong links to these populations to meet their specific HIV prevention needs. As part of these awards, each organization will be required to provide specific prevention services. These include providing HIV testing to a total of more than 90,000 young gay and bisexual men and transgender youth of color, with a goal of identifying more than 3,500 previously unrecognized HIV infections (over the five-year funding period) – and linking those who are HIV-infected to care and prevention services. CBOs will also carry out proven behavioral change HIV prevention programs and distribute condoms to young gay and bisexual men and transgender youth of color who are at high risk for HIV or are HIV-infected.

Read the rest.


[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Young people lead HIV prevention revolution: AU

via  The Zimbabwean, by Francis Rwodzi

Young people are leading the prevention revolution by increasingly acting to protect themselves from HIV said the African Union (AU) during the pre-summit African Youth Forum that was held at the AU Headquarters in Addis Ababa, Ethiopia last week.

The “prevention revolution” is a global commitment by UNAIDS and its co-sponsors to galvanize leaderships at all levels, communities and all key stakeholders and development partners to halt the HIV epidemic-the ultimate vision is zero new infections , zero discrimination and zero deaths.

The revolution requires greatly intensified efforts to address the needs of all those at risk of infection, and of everyone living with HIV, with quality, scaled up programmes based on evidence of what works.

The AU said that only by stemming the tide of new HIV infections can those already HIV positive be assured life-time care, treatment and support and efforts are targeted at those countries and populations where the most new infections are occurring, especially the high prevalence countries in eastern and southern Africa.

Statistics released by the AU revealed that although there were 1.8 million new HIV infections in sub Saharan Africa during 2009, 22 countries reported a prevalence decline of more than 25 percent. The statistics showed that the number of young people living with HIV is falling in 13 African countries, a tremendous achievement on which African government can build on.

Read the rest.

[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

MTV Drama Raising HIV Awareness in Africa

From CNN, by Tom Hayes

"It's the story of morning afters and sweet departures...and the stains we leave on each other." -From the trailer of Shuga, a cutting-edge MTV drama that's been a smash hit in Africa.

For many young Africans, the three-part TV series about a group of students in Nairobi living under the constant specter of HIV/AIDS is the story of their own lives -- and is the reason "Shuga" took the continent by storm when it debuted late last year.

Actress Sharon Olago, who played promiscuous party girl Violet in "Shuga," believes the Kenyan show has been so successful because it mirrors the complexities of modern young life, without falling into a moralistic, conventional narrative on safe sex.

"'Shuga' did not exaggerate anything, it relived what Kenya is," says Olago. "That is why it got the fame it did, that is why people jumped into it, because people saw themselves in it."

Set and filmed on location in Nairobi, the soap opera came about after UNICEF teamed up with MTV to create a health campaign to impact the lives of youths in Kenya, where an estimated 6.5 percent of its population lives with HIV.

Read the rest and watch a clip

JAIDS: Youth-Specific Considerations in the Development of Preexposure Prophylaxis, Microbicide, and Vaccine Research Trials

Full article - free [includes a section on rectal microbicides]

This article is one of several from the July 1, 2010 - Volume 54 - Supplement 1, "Inclusion of Adolescents and Young Adults in Biomedical HIV Prevention Research" - click here to read the rest
 

JAIDS Journal of Acquired Immune Deficiency Syndromes:

1 July 2010 - Volume 54 - Issue - pp S31-S42

doi: 10.1097/QAI.0b013e3181e3a922

Supplement Article

Rudy, Bret J MD; Kapogiannis, Bill G MD; Lally, Michelle A MD, MSc; Gray, Glenda E MBBCH, FCPaeds(SA); Bekker, Linda-Gail MBCHB, FCP, PhD; Krogstad, Paul MD; McGowan, Ian MD, PhD

Abstract:

Preventing HIV infection in adolescents and young adults will require a multimodal targeted approach, including individual-directed behavioral risk reduction, community-level structural change, and biomedical interventions to prevent sexual transmission. Trials testing biomedical interventions to prevent HIV transmission will require special attention in this population due to the unique psychosocial and physiologic characteristics that differentiate them from older populations. For example, microbicide research will need to consider acceptability, dosing requirements, and coinfection rates that are unique to this population. Preexposure prophylaxis studies also will need to consider potential unique psychosocial issues such as sexual disinhibition and acceptability as well as unique pharmacokinetic parameters of antiretroviral agents. Vaccine trials also face unique issues with this population, including attitudes toward vaccines, risks related to false-positive HIV tests related to vaccine, and different immune responses based on more robust immunity. In this article, we will discuss issues around implementing each of these biomedical prevention modalities in trials among adolescents and young adults to help to guide future successful research targeting this population.

Read the whole article.